Users Discontinuing Slimming Injections Regain Pounds at a Quadrupled Rate Than Those on Conventional Diets

A recent study reveals that people who stop using blockbuster GLP-1 drugs like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who halt traditional diet and exercise programs.

Published data in a major medical journal demonstrates that while overweight people can lose substantial amounts of their body weight while using the jabs, the weight is regained at an average rate of nearly a kilo each month after stopping.

"Individuals purchasing such treatments should be aware of the potential of quick rebound weight gain when the therapy concludes," stated researcher Dr. Susan Jebb.

This pace of recovery suggests a return to starting mass in about a year and a half.

Comparing Treatments

The research, which reviewed dozens of trials involving thousands of participants, compared the outcomes of these new drugs with conventional dieting.

Researchers emphasize that individuals who lose weight through diet and exercise typically have a more gradual creep back—around 0.1 kg a month—post-intervention.

The Reason for the Fast Regain

Nutrition scientists propose the mechanism of the jabs accounts for the amplified rebound.

The injections copy a natural hormone called glucagon-like peptide-1, which moderates hunger.

"Long-term administration of GLP-1 levels several times higher than the body's typical production could lead to the system to generate a reduced amount of its endogenous hormone, and could lessen sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.

"Withdrawal of this medication means hunger is uncontrolled, making binge eating a significant risk."

A Lifelong Issue?

Health authorities recommend the injections for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.

A number of clinicians say that, considering the high risk of relapse, the therapy might need to be life-long.

This view is echoed by pharmaceutical companies, who state that the results "underscore the long-term character of excess weight," comparing it to managing conditions like diabetes.

Patient Accounts

Individuals who have stopped the jabs explain a powerful return of cravings.

"It was like a trigger that goes on and you're instantly extremely hungry," recalled an individual.

This challenge is worsened if individuals have not established permanent lifestyle or habit modifications during therapy.

Significant Use

Survey data indicate that a significant number of people in the UK have used these injections in the last 12 months, with desire remaining high.

• Adoption is higher among women compared to men.
• The 40s and 50s age group shows the highest usage rates.
• Many obtain the medications through private healthcare rather than public health services.

Ultimately, clinicians emphasize that while the jabs are powerful agents for shedding pounds, they are not a magic cure and lasting health benefits relies on ongoing lifestyle management.